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Background: The evolutionary changes in mycobacterium tuberculosis (MTB) have been
phenotypic as well as genotypic by diversifying into various lines of descent or lineages.
Methodology and findings: A total of 538 MTB isolates obtained from different parts of India
were included in the study. Spoligotyping and drug susceptibility testing was performed on
all the MTB isolates. Major cities and parts of India from where these isolations were made
include: Delhi, Assam, Punjab, Maharashtra (Nagpur, Mumbai), Tamilnadu (Chennai), Uttar
Pradesh (Agra), and West Bengal (Kolkata). Spoligotyping analysis detected 93 distinct spol-
igo-patterns. A total of 440 (81.7%) isolates could be grouped into 77 SITs which matched
the pre-existing database, whereas 16 SITs were newly created for 51 (9.7%) isolates and
for 47 (8.7%) isolates no SIT number could be assigned and these were grouped as ‘orphans’.
Overall, CAS family was predominant, comprised of 37.9% isolates, followed by EAI 23.6%,
Beijing in 13.9%, Manu in 6.8% and T in 4.6% isolates. Other families were rare. Drug suscep-
tibility testing (DST) identified 361 (67.1%) isolates as pan-sensitive to all 4 first-line drugs,
83 (15.4%) were resistant to any one or more drugs, and 94 (17.4%) were identified as mul-
tidrug-resistant (MDR). Out of the 94 MDR isolates, the majority of isolates (32; 34%) were
Beijing, 31 (32%) CAS, 11 (11.7%) unknown, and 6 (6.3%) each of EAI and T lineages. Among
the Beijing lineage, SIT621 was more associated with MDR-TB compared with SIT1.
Conclusions: The study provides important baseline data to understand and monitor the
molecular epidemiology of MTB in India. The CAS lineage was the most common and
widely prevalent across India, while EAI lineage was more common in south and eastern
India. The Beijing lineage was significantly (p-value <0.0001) associated with MDR-TB.
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